WALTHAM, Mass.--(BUSINESS WIRE)--
Every hour sepsis goes untreated, mortality risk increases by about 8%.1 Early, accurate detection of patients with sepsis is essential to ensuring sepsis bundle compliance, improving clinical outcomes, and reducing costs from an extended length of stay (LOS). has expanded the Sentri7® suite of clinical surveillance tools to include – empowering hospitals and health systems to identify sepsis earlier and supporting staff in delivering the best care everywhere.
Sentri7 Sepsis Monitor (formerly known as POC Advisor) leverages clinical natural language processing (cNLP) and advanced algorithms to surveil a hospital's patients 24/7 to identify early signs of sepsis. The solution also monitors patient care and notifies clinical teams of deviations from the evidence-based SEP-1 protocol, eliminating unwarranted variation in care and improving quality and financial performance. A study published in the observed a sensitivity of 95% and specificity of 82% for detecting sepsis compared to gold-standard physician chart review.2
Powering rapid sepsis improvement at Conway Regional Medical Center
Using Wolters Kluwer’s Sentri7 Sepsis Monitor, , a 150-bed hospital serving North Central Arkansas, improved its SEP-1 bundle compliance by more than 20% in just over four months —placing them in the top decile of institutions nationwide based on internal case tracking. During the same period, the hospital also achieved cumulative savings of nearly $400,000 as a result of sepsis care improvements and other initiatives to reduce patients’ length of stay.
“We looked to Wolters Kluwer to provide the advanced, automated sepsis surveillance, clinical decision support, and access to its team of clinical, informatics, and operations experts to help jumpstart the revamp of our sepsis program,” said James Reed, PharmD, Chief Information Officer, Conway Regional Medical Center. “Sentri7 Sepsis Monitor empowers our care team with valuable and actionable decision support and the data required to improve sepsis detection and manage care proactively.”
Expanding the Sentri7 suite of clinical surveillance solutions
Like Sentri7 infection prevention and pharmacy users, hospitals that have implemented Sepsis Monitor have access to Wolters Kluwer’s evidence-based curated content, customized workflows, and embedded analytics. Sepsis Monitor uses the same platform technology but also leverages clinically maintained sepsis algorithms and tailored workflows to drive more sophisticated patient identification and effectively manage patient care throughout their stay and staff transition.
“Hospitals have long relied on Sentri7 surveillance to improve patient management, outcomes, and quality of care for pharmacy and infection prevention. Now, we’re delivering this facility-wide surveillance capability for better sepsis performance,” said , Vice President and General Manager of Clinical Surveillance Compliance & Data Solutions, Wolters Kluwer, Health. “We make it easy with Sentri7’s suite of solutions deployed on a single technology platform so customers can easily adopt new solutions like Sepsis Monitor with minimal engagement of resource-constrained IT teams.”
Specific features of Sentri7 Sepsis Monitor include:
- Patient monitoring dashboard empowers sepsis coordinators and rapid response teams to surveil a hospital continuously and sends advanced alerts to SEP-1 bundle care steps
- Evidence-based patient identification alerts that also provide clinical context for why the alert fired and evidence-based guidance for the next steps in care
- Integrated workflows that deliver alerts to bedside clinical care teams through the EHR, mobile communication devices, and hospital-wide central monitoring systems
- Advanced clinical natural language processing that assesses clinical notes in real-time for critical information missing from standardized EHR data that might indicate sepsis and rules out comorbidities that may trigger false alerts
- Robust analytics dashboards equip quality improvement teams to target specific areas of opportunity to improve bundle compliance, LOS, and mortality to improve patient care.
Click to learn more about Sentri7’s suite of clinical surveillance solutions, including Sepsis Monitor.
About Wolters Kluwer
Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.
Wolters Kluwer reported 2021 annual revenues of €4.8 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,800 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.
Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. We support clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions. For more information about our solutions, visit and follow us on and Twitter .
For more information, visit , follow us on , , , and .
1 Ferrer et al. (2014). . Critical Care Medicine.
2 Sharad Manaktala (2017). Evaluating the impact of a computerized surveillance algorithm and decision support system on sepsis mortality. JAMIA.
View source version on businesswire.com:
